PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share (PAHC) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2014 to Q4 2025

Type / Class
Equity / Class A Common Stock, par value $0.0001 per share
Symbol
PAHC on Nasdaq
Shares outstanding
40,568,426
Price per share
$37.36
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
19,599,540
Total reported value
$792,990,412
% of total 13F portfolios
0%
Share change
-764,500
Value change
-$21,506,323
Number of holders
215
Price from insider filings
$37.36
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share (PAHC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BFI Co., LLC 49% -1.2% $906,610,607 -$10,211,942 20,000,234 -1.1% BFI Co., LLC 11 Dec 2025
BlackRock, Inc. 16% $57,576,134 3,195,124 BlackRock, Inc. 31 Mar 2025
PZENA INVESTMENT MANAGEMENT LLC 3.6% -51% $13,043,417 -$13,280,199 723,830 -50% PZENA INVESTMENT MANAGEMENT LLC 31 Mar 2025
BRANDES INVESTMENT PARTNERS, LP 3.3% $11,942,719 662,748 Brandes Investment Partners, L.P. 31 Dec 2024

As of 30 Sep 2025, 215 institutional investors reported holding 19,599,540 shares of PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share (PAHC). This represents 48% of the company’s total 40,568,426 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share (PAHC) together control 34% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 8.4% 3,426,171 -1.9% 0% $138,622,879
VANGUARD GROUP INC 3.8% 1,525,709 -1.5% 0% $61,730,187
STATE STREET CORP 2.2% 894,036 -1.7% 0% $36,172,697
ACADIAN ASSET MANAGEMENT LLC 1.9% 785,820 +8.5% 0.06% $31,780,000
FMR LLC 1.5% 597,555 +903% 0% $24,177,071
RENAISSANCE TECHNOLOGIES LLC 1.4% 555,200 -9.1% 0.03% $22,463,392
GEODE CAPITAL MANAGEMENT, LLC 1.3% 547,160 -1.4% 0% $22,141,619
DIMENSIONAL FUND ADVISORS LP 1.2% 485,509 -13% 0% $19,641,321
Nuveen, LLC 1.2% 479,218 +4.2% 0.01% $19,389,160
MORGAN STANLEY 1.1% 436,042 -11% 0% $17,642,318
CastleKnight Management LP 0.99% 399,783 -25% 0.87% $16,175,220
Dana Investment Advisors, Inc. 0.88% 355,085 -9.6% 0.42% $14,366,739
Invesco Ltd. 0.79% 322,299 +23% 0% $13,040,217
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.74% 301,605 +9.6% 0.01% $12,202,938
Ranger Investment Management, L.P. 0.74% 299,910 -16% 0.85% $12,134,359
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.67% 271,163 +4.3% 0% $10,971,255
BARCLAYS PLC 0.66% 269,568 +47% 0% $10,906,721
Bank of New York Mellon Corp 0.66% 267,103 -0.66% 0% $10,806,984
Qube Research & Technologies Ltd 0.63% 255,353 +40% 0.01% $10,331,582
Capricorn Fund Managers Ltd 0.62% 252,928 3.4% $10,233,467
JPMORGAN CHASE & CO 0.59% 238,115 +1731% 0% $9,634,134
GLOBEFLEX CAPITAL L P 0.57% 231,499 +1.8% 1.4% $9,366,450
NORTHERN TRUST CORP 0.55% 221,861 -1.2% 0% $8,976,497
Allspring Global Investments Holdings, LLC 0.54% 218,894 0.01% $8,930,876
CRAWFORD INVESTMENT COUNSEL INC 0.54% 217,636 -7.8% 0.15% $8,805,556

Institutional Holders of PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share (PAHC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 183,358 $6,855,319 -$3,200,536 $37.36 10
2025 Q3 19,599,540 $792,990,412 -$21,506,323 $40.46 215
2025 Q2 20,349,724 $519,721,694 +$4,932,349 $25.54 192
2025 Q1 20,230,331 $431,882,531 -$6,976,163 $21.36 181
2024 Q4 20,760,076 $435,958,146 +$5,855,068 $21.00 171
2024 Q3 20,262,212 $456,562,597 +$4,978,935 $22.52 145
2024 Q2 20,104,261 $337,332,099 -$3,613,178 $16.77 138
2024 Q1 20,390,841 $263,815,154 +$4,780,079 $12.93 137
2023 Q4 20,498,053 $237,357,830 +$2,393,108 $11.58 134
2023 Q3 20,056,787 $257,066,743 +$637,840 $12.77 124
2023 Q2 19,973,690 $273,662,577 -$4,846,655 $13.70 127
2023 Q1 20,301,393 $311,012,290 +$5,422,420 $15.32 132
2022 Q4 19,989,777 $268,089,718 +$1,271,732 $13.41 129
2022 Q3 19,929,636 $264,908,464 -$16,816,591 $13.29 138
2022 Q2 20,667,086 $395,381,581 +$3,633,408 $19.13 139
2022 Q1 20,531,472 $408,823,760 +$4,262,047 $19.95 143
2021 Q4 20,288,359 $413,858,025 -$6,010,185 $20.42 133
2021 Q3 20,413,494 $439,740,209 -$19,573,080 $21.54 130
2021 Q2 21,302,215 $615,117,148 +$14,536,483 $28.88 142
2021 Q1 21,042,222 $513,508,005 +$22,206,837 $24.40 137
2020 Q4 20,306,618 $394,390,866 -$4,768,468 $19.42 129
2020 Q3 20,646,036 $359,251,334 -$10,719,506 $17.40 131
2020 Q2 44,667,289 $1,140,259,090 +$598,684,081 $26.27 148
2020 Q1 20,463,242 $494,535,691 -$12,127,558 $24.17 148
2019 Q4 20,557,292 $510,464,148 +$14,222,033 $24.83 148
2019 Q3 20,621,951 $440,106,105 -$15,741,828 $21.33 147
2019 Q2 21,057,891 $668,876,686 +$39,304,468 $31.77 164
2019 Q1 20,438,371 $674,469,078 +$6,675,566 $33.00 173
2018 Q4 20,247,477 $651,077,628 +$2,126,967 $32.16 187
2018 Q3 20,133,697 $863,784,342 +$21,235,963 $42.90 188
2018 Q2 19,602,864 $902,263,512 +$26,896,969 $46.05 170
2018 Q1 19,555,491 $776,428,353 +$30,646,488 $39.70 167
2017 Q4 19,277,485 $646,026,747 -$9,662,597 $33.50 166
2017 Q3 19,413,132 $719,096,867 +$10,843,119 $37.05 160
2017 Q2 19,118,590 $707,142,729 +$31,448,680 $37.05 165
2017 Q1 18,613,735 $523,086,692 +$94,557,319 $28.10 151
2016 Q4 18,454,313 $541,292,006 -$4,782,470 $29.30 139
2016 Q3 18,623,231 $506,139,803 +$7,597,360 $27.18 119
2016 Q2 18,864,791 $352,709,535 -$18,147,622 $18.66 120
2016 Q1 19,230,618 $520,246,100 -$23,256,316 $27.04 120
2015 Q4 20,005,841 $602,775,758 +$44,273,288 $30.13 120
2015 Q3 18,566,690 $587,300,237 +$44,210,194 $31.63 121
2015 Q2 17,185,940 $669,156,762 -$1,896,768 $38.94 119
2015 Q1 17,343,808 $613,840,303 +$318,429 $35.41 107
2014 Q4 17,598,205 $554,999,626 +$4,023,253 $31.55 90
2014 Q3 17,459,966 $391,274,678 +$65,706,329 $22.41 68
2014 Q2 14,541,709 $319,188,457 +$319,161,458 $21.95 64